Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-FR | Version v4-EN | |
---|---|---|
Language | French | English |
Date Updated | 2021-12-14 | 2021-07-12 |
Drug Identification Number | 02441691 | 02441691 |
Brand name | PRISM0CAL B22K0/0 | PRISM0CAL B22K0/0 |
Common or Proper name | PRISM0CAL B22K0/0 | PRISM0CAL B22K0/0 |
Company Name | VANTIVE ULC | VANTIVE ULC |
Ingredients | SODIUM BICARBONATE SODIUM CHLORIDE MAGNESIUM CHLORIDE | SODIUM BICARBONATE SODIUM CHLORIDE MAGNESIUM CHLORIDE |
Strength(s) | 2.12G 7.14G 3.05G | 2.12G 7.14G 3.05G |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | DIALYSIS INTRAVENOUS DIALYSIS INTRAVENOUS | DIALYSIS INTRAVENOUS DIALYSIS INTRAVENOUS |
Packaging size | 5L Bags (Product Code 115295) | 5L Bags (Product Code 115295) |
ATC code | B05ZB | B05ZB |
ATC description | HEMODIALYTICS AND HEMOFILTRATES | HEMODIALYTICS AND HEMOFILTRATES |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | 2021-07-11 | 2021-07-11 |
Actual start date | 2021-07-11 | |
Estimated end date | 2022-06-30 | Unknown |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | PrismaSOL 0 (113881)/ PrismaSOL 4 (113883)/ Prism0CAL (113884) / Prism0CAL B22 (115295) CRRT Solution is currently on 75% allocation, which means that 75% of a customer’s historic monthly demand would be automatically fulfilled. Any orders above this amount would require a customer to request an additional release through our customer care team for consideration. Demand for this product remains high, thus posing a risk for intermittent branch-level and/or national back orders over the next 2-4 months. | PrismaSOL 0 (113881)/ PrismaSOL 4 (113883)/ Prism0CAL (113884) / Prism0CAL B22 (115295) CRRT Solution is currently on 75% allocation, which means that 75% of a customer’s historic monthly demand would be automatically fulfilled. Any orders above this amount would require a customer to request an additional release through our customer care team for consideration. Demand for this product remains high, thus posing a risk for intermittent branch-level and/or national back orders over the next 2-4 months. |
Health Canada comments |